Press releasePRNewswire
Senestech
SNES · NASDAQ
$0.6893−$0.0107 (−1.53%)TodayMarket closed ·
Prev close $0.70
Latest news
- Press releaseGlobe Newswire
SenesTech Reports 88% Reduction in Rat Activity in Chicago Pilot, Building on Record $1.1 Million Quarterly Revenue Milestone
- Press releaseGlobe Newswire
SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth
- Press releasePRNewswire
SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth
- Press releasePRNewswire
SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused Consumers
- Press releasePRNewswire
SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference
- Press releasePRNewswire
Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity with Evolve® Rat
- Press releasePRNewswire
SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Press releasePRNewswire
SenesTech to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releasePRNewswire
SenesTech Reports Record Q2 2026 Revenue and Gross Margin as E-commerce Growth Accelerates
- Press releasePRNewswire
SenesTech Adds Assessment Services to Help B2B Customers Better Understand Rodent Infestations
- Press releasePRNewswire
SenesTech Active Subscriber Base More Than Doubles as E-commerce Strategy Gains Momentum
- Press releasePRNewswire
SenesTech to Report Second Quarter 2026 Financial Results on Wednesday, August 5, 2026
- Press releasePRNewswire
SenesTech's Evolve® Delivers Significant Reduction in Rodent Damage at Texas Agricultural Operation
- Press releasePRNewswire
SenesTech Appoints Jack Karabees as Executive Vice President of Sales
- Press releasePRNewswire
SenesTech Expands Distribution of Evolve® Rodent Birth Control™ into Bermuda
- Press releasePRNewswire
SenesTech Announces Amendment to Equity Incentive Plan Proposal
- Press releasePRNewswire
SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
- News
SenesTech Q1 2026 Earnings Call: Complete Transcript
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releasePRNewswire
SenesTech Reports Record Direct-to-Consumer and Subscription Growth Following Strategic E-Commerce Transition
- News
Earnings Scheduled For May 12, 2026
- Press releasePRNewswire
SenesTech to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releasePRNewswire
SenesTech Appoints Michael Edell as President and Chief Executive Officer to Drive Revenue Growth and Scalable Sales Channels
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releasePRNewswire
SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce
- News
Earnings Scheduled For March 12, 2026
- Press releasePRNewswire
SenesTech to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Thursday, March 12, 2026
- Press releasePRNewswire
SenesTech Reports Significant Reductions in Rodent Activity Following Evolve® Deployments in Urban Field Studies
- Press releasePRNewswire
SenesTech Strengthens Direct-to-Consumer Commercial Strategy by Directly Managing Amazon Sales of Evolve™ Rat and Evolve™ Mouse
- Press releasePRNewswire
SenesTech's Evolve® Approved in New Zealand
- Press releasePRNewswire
SenesTech Announces CEO Transition Plan
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.